NovaBay Pharmaceuticals, Inc. (NBY) Social Stream
NovaBay Pharmaceuticals Inc (NBY) Price Targets From Analysts
Use the tables below to see what analysts covering NovaBay Pharmaceuticals Inc think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued November 15, 2021
Over the past 38 days, NBY's average upside potential has been 303.59%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
NBY Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how NovaBay Pharmaceuticals Inc fares relative to all US stocks, note that its number of analysts covering the stock is greater than just about none of of that group.
- NBY has a lower variance in analysts' estimates than almost 100% of all US stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, NovaBay Pharmaceuticals Inc's average analyst price target is greater than 1.07% of them.
- NovaBay Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is higher than 88.68% of Healthcare stocks.
What is the outlook for NBY? Use POWR Ratings for clearer insight into price direction.